Cardiology journals retract five Matsubara studies

The American Heart Association (AHA) is retracting five studies by Hiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher, that it had subjected to an expression of concern last year.

Here’s the notice:

Ulrich Lichtenthaler now up to 12 retractions

Industrial and Corporate Change is the site of management professor Ulrich Lichtenthaler’s 12th retraction.

Here’s the notice for “Outward knowledge transfer: the impact of project-based organization on performance,” originally published in 2010:

Cell attributes image problems in cloning paper to “minor” errors; sees no impact on conclusions

Yesterday we reported that Cell was looking into problematic images in a recent paper on human embryonic stem cell cloning. We’ve now heard from the journal about the nature of the inquiry.

Mary Beth O’Leary, a spokeswoman for Cell Press — an Elsevier title — tells us that:

Based on our own initial in-house assessment of the issues raised in PubPeer and in initial discussions with the authors, it seems that there were some minor errors made by the authors when preparing the figures for initial submission.  While we are continuing discussions with the authors, we do not believe these errors impact the scientific findings of the paper in any way. 

Author break prompts retraction of bone protein paper

The European Journal of Pharmacology has — against its will, it would seem — retracted a 2012 paper by a group of Chinese heart researchers embroiled in a what appears to be a rather messy authorship dispute.

The article, “The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat,”  came from the Institute of Cardiovascular Disease at Tongji Hospital, part of of Huazhong University of Science and Technology.

As the retraction notice states:

Dodgy figure in cord blood paper prompts Expression of Concern in oncology journal

The editor of Clinical Medicine Insights: Oncology has issued an Expression of Concern over a 2008 paper by a group of authors in China after identifying “flaws” in one of the figures.

The article, “Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment,” purported to show that:

tumor-specific antigens present on exosomes can be presented by DCs [dendritic cells] derived from unrelated umbilical cord blood to induce tumor specific cytotoxicity and this may represent as a novel immunotherapy for ovarian cancer.

But according to William C. S. Cho, editor of the journal, there’s reason to doubt the conclusions. As the notice explains:

Tenth retraction appears for Jesús Lemus, this one in PLOS ONE

Just two days ago, we covered the ninth retraction for Jesús Lemus, “the veterinary researcher whose work colleagues have had trouble verifying, including being unable to confirm the identity of one of his co-authors.” And already another of his retractions has appeared in one of our daily alerts.

This one appears in PLOS ONE, for “Infectious Offspring: How Birds Acquire and Transmit an Avian Polyomavirus in the Wild:”

Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper

Cell is looking into whether the authors of a widely hailed study published last week claiming to have turned human skin cells into embryonic stem cells manipulated images inappropriately, Retraction Watch has learned.

The potential image problems came to light on PubPeer, a site designed to allow for post-publication peer review. A commenter, identified as Peer1, identified “several examples of image reuse which might be of interest to PubPeer members and readers:”